White label ELPA - ClinicalTrials.eu

Study to evaluate the effects of brexanolone and lorazepam on the nervous system in healthy male participants using magnetic brain stimulation

Not recruiting

1 1 1
Investigated Drugs:
- Lorazepam
A study to compare how the body absorbs empagliflozin tablets in healthy individuals.

Not recruiting

1 1 1 1
Investigated Drugs:
- Empagliflozin
Evaluation of Pembrolizumab, Patritumab Deruxtecan, and Drug Combinations in Stage IV Non-Small Cell Lung Cancer: A Phase 2 Umbrella Study

Not recruiting

2 1 1 1
Investigated Diseases:
- Lung neoplasm malignant
Investigated Drugs:
Study of BI 1810631 (C‑14) oral solution, BI 1810631 (C‑14) IV microtracer, and BI 1810631 tablet to assess absorption and metabolism in healthy men

Not recruiting

1 1 1
Investigated Drugs:
- Zongertinib
Safety and Tolerability of Topical Iodine (DLQ03) in Patients with Mild to Moderate Atopic Dermatitis Colonized with Staphylococcus aureus

Not recruiting

2 1 1
Investigated Diseases:
- Dermatitis atopic
Efficacy and Safety Evaluation of Belantamab Mafodotin Versus Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients

Not recruiting

3 1 1 1
Investigated Diseases:
- Plasma cell myeloma
Investigated Drugs:
+4
Phase 1 Study of REN001 Single‑Dose Pharmacokinetics in Adults with Normal, Mild, Moderate, or Severe Liver Impairment

Not recruiting

1 1 1
Comparison of montelukast 10 mg capsules and montelukast 10 mg film-coated tablets in healthy volunteers to evaluate how the medicine is absorbed.

Not recruiting

1 1 1 1
Investigated Diseases:
- Asthma
Investigated Drugs:
- Montelukast
Comparative Bioavailability of Inhaled Levodopa (Levodopa Cyclops) versus Inhaled Levodopa Powder with Carbidopa in Healthy Adults for Parkinson’s Disease

Not recruiting

1 1 1 1
Investigated Diseases:
- Parkinson’s disease
Investigated Drugs:
- Carbidopa
- Levodopa
Phase 3 Study of Subcutaneous Pembrolizumab with Hyaluronidase vs. Intravenous Pembrolizumab in Metastatic NSCLC with PD-L1 TPS ≥50%

Not recruiting

3 1 1 1
Investigated Drugs:
- Pembrolizumab

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies